 | Up a level |
van Santen, Daniela K; Stewart, Ashleigh; Doyle, Joseph S; Stoové, Mark A; Asselin, Jason; Klein, Marina B; Young, Jim; Berenguer, Juan; Jarrin, Inmaculada; Lacombe, Karine; Wittkop, Linda; Leleux, Olivier; Salmon, Dominique; Bonnet, Fabrice; Rauch, Andri; Mugglin, Catrina; Matthews, Gail; Prins, Maria; Smit, Colette; Boyd, Anders; ... (2024). Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC). International journal of epidemiology, 53(1) Oxford University Press 10.1093/ije/dyad154
Requena, Maria-Bernarda; Protopopescu, Camelia; Stewart, Ashleigh C; van Santen, Daniela K; Klein, Marina B; Jarrin, Inmaculada; Berenguer, Juan; Wittkop, Linda; Salmon, Dominique; Rauch, Andri; Prins, Maria; van der Valk, Marc; Sacks-Davis, Rachel; Hellard, Margaret E; Carrieri, Patrizia; Lacombe, Karine (2024). All-cause mortality before and after DAA availability among people living with HIV and HCV: An international comparison between 2010 and 2019. The international journal of drug policy, 124(104311), p. 104311. Elsevier 10.1016/j.drugpo.2023.104311
Sacks-Davis, Rachel; van Santen, Daniela K; Boyd, Anders; Young, Jim; Stewart, Ashleigh; Doyle, Joseph S; Rauch, Andri; Mugglin, Catrina; Klein, Marina; van der Valk, Marc; Smit, Colette; Jarrin, Inmaculada; Berenguer, Juan; Lacombe, Karine; Requena, Maria-Bernarda; Wittkop, Linda; Leleux, Olivier; Bonnet, Fabrice; Salmon, Dominique; Matthews, Gail V; ... (2024). Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010-19: an analysis of data from a consortium of prospective cohort studies. The Lancet HIV, 11(2), e106-e116. Elsevier 10.1016/S2352-3018(23)00267-9
Isfordink, Cas J; Boyd, Anders; Sacks-Davis, Rachel; van Santen, Daniela K; Smit, Colette; Martinello, Marianne; Stoove, Mark; Berenguer, Juan; Wittkop, Linda; Klein, Marina B; Rauch, Andri; Salmon, Dominique; Lacombe, Karine; Stewart, Ashleigh; Schinkel, Janke; Doyle, Joseph S; Hellard, Margaret; van der Valk, Marc; Matthews, Gail V (2023). Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study. The lancet. Public health, 8(4), e294-e304. Elsevier 10.1016/S2468-2667(23)00056-7
van Santen, Daniela K; Sacks-Davis, Rachel; Stewart, Ashleigh; Boyd, Anders; Young, Jim; van der Valk, Marc; Smit, Colette; Rauch, Andri; Braun, Dominique L; Jarrin, Inmaculada; Berenguer, Juan; Lazarus, Jeffrey V; Lacombe, Karine; Requena, Maria-Bernarda; Wittkop, Linda; Leleux, Olivier; Salmon, Dominique; Bonnet, Fabrice; Matthews, Gail; Doyle, Joseph S; ... (2023). Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: Findings from a multinational cohort between 2010 and 2019. EClinicalMedicine, 56, p. 101810. Elsevier 10.1016/j.eclinm.2022.101810
